Epidural Stimulation for Upper Extremity Function
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBrigham and Women's Hospital
About this trial
Restoring upper extremity function in patients with cervical spinal cord injury is extremely important for patients' independence and quality of life.
At present, there are limited options for hand or arm reanimation in this patient population. Nerve transfer is one such option that can partially restore the natural movement of hand or arm function in select patients.
The investigators are interested in understanding whether recovery of hand or arm motor function after nerve transfer can be augmented by cervical epidural spinal cord stimulation.
Eligibility criteria
Qualifiers
Age ≥18 years and ≤65
Provides informed consent
History of upper extremity nerve transfer > 6 months prior to enrollment
Completion of standard post-nerve transfer occupational therapy
Disqualifiers
Central nervous system (CNS) malignancy
A contraindication to the SCS procedure
Diagnosis that precludes the patient from full participation in the protocol
A functional implanted device (pacemaker, vagus nerve device, baclofen pump)
Trial design
Treatments tested in this trial
- Percutaneous spinal cord stimulation
Treatment groups
20 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov